This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Efficacy of Endocell® vs Conventional Medium in the Treatment of Infertility

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2010 by Laboratoires Genévrier.
Recruitment status was:  Recruiting
Information provided by:
Laboratoires Genévrier Identifier:
First received: January 27, 2010
Last updated: February 3, 2010
Last verified: February 2010
The aim of this study is to demonstrate the efficacy of a single embryo transfer at blastocyst stage (Day 5) after co-culture on Autologous Endometrial Cell Culture (AECC) versus transfer of a single embryo at Day 3 after culture in conventional medium. Efficacy will be assessed in terms of clinical pregnancy rate 5 to 8 weeks after embryo transfer.

Condition Intervention Phase
Infertility Other: - Conventional culture medium for IVF Other: - Endocell® Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Multicentre, Randomised, Controlled Clinical Study on the Efficacy in Terms of Clinical Pregnancy Rate of 1 Embryo Transfer at Day 5 After Co-culture on Autologous Endometrial Cells(ENDOCELL®) Versus 1 Embryo Transfer at Day 3 After Culture on Conventional Medium.

Resource links provided by NLM:

Further study details as provided by Laboratoires Genévrier:

Estimated Enrollment: 720
Study Start Date: February 2008
Arms Assigned Interventions
Active Comparator: D3 Other: - Conventional culture medium for IVF
Embryos are cultured on conventional medium and transferred at Day 3. Supernumerary good quality embryos are frozen
Experimental: D5 Other: - Endocell®
Embryos are cultured on ENDOCELL® from Day 2 to Day 5 (Blastocyst stage) One embryo is transferred at Day 5. Supernumerary good quality embryos are frozen.


Ages Eligible for Study:   18 Years to 36 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Women aged ≥ 18 and ≤ 36
  • Undergoing ovarian stimulation for an In Vitro Fertilization (IVF) or Intra Cytoplasmic Sperm Injection (ICSI)
  • Having experienced no more than 1 Embryo Transfer failure
  • With basal FSH level ≤ 12 IU/l within the 6 months prior to the study
  • Endometrial biopsy during the menstrual cycle preceding the ovarian stimulation (6 to 12 days after a documented ovulation)
  • Negative serology for HIV 1 and 2, hepatitis B and C, HTLV 1 and 2, syphilis

Exclusion Criteria:

  • Hypersensitivity to one of the culture media components
  • Oocyte donation, sperm donation
  • Thawed embryos transfer
  • Women with endometriosis grade III and IV, chronic endometritis, hydrosalpinx, polycystic ovary, amenorrhoea, anovulation, uterus with malformation, uncontrolled prolactinaemia, uterine synechia, uterine fibroma, women exposed to distilbene, uterine polyps
  • Women affected by pathologies associated with any contraindication of being pregnant
  • Abnormal gynaecologic bleeding of undetermined origin
  • Uncontrolled thyroid (TSH dosage) or adrenal dysfunction
  • Neoplasias, any pathologies of the endometrium or the cervix
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01058603

Contact: Anissa Benoussaidh +33-492914134

CMCO Recruiting
Schiltigheim, France, 67303
Contact: Jeanine Ohl, MD    00 (33)   
Sponsors and Collaborators
Laboratoires Genévrier
  More Information

Responsible Party: Laboratoires Genévrier Identifier: NCT01058603     History of Changes
Other Study ID Numbers: 07F/END01
Study First Received: January 27, 2010
Last Updated: February 3, 2010

Keywords provided by Laboratoires Genévrier:
Cell Culture

Additional relevant MeSH terms:
Genital Diseases, Male
Genital Diseases, Female processed this record on September 21, 2017